Steven T Minor, MD

Specialty:

Clinical and Invasive Cardiology

Office Locations:

San Marcos, Austin Heart - Lockhart

Personal Interests:

Ranching and fishing

Professional Associations:

• American College of Cardiology, Fellow
• American Medical Association
• American Heart Association
• Texas Medical Association

Professional Affiliations:

• Austin Heart, Board of Directors, Member (1997-present)
• Central Texas Medical Center, Director of Cardiac Cath Lab (1996-present)
• Central Texas Medical Center, Director of Intensive Care Unit (1996-present)
• Central Texas Medical Center, President of Medical Staff (1998-1999)

Book Chapter:

• Kleiman NS, Goldberg RK, Minor ST. Percutaneous transluminal coronary angioplasty in the treatment of patients with unstable angina and acute myocardial infarction. In Advances in Interventional Cardiology, PA Majid, ed. JB Lippincott Co., Philadelphia, 1988.

Scientific Papers in Peer Reviewed Journals:

• Minor ST, Taylor K, Knight TF, Senekjian HO, Weinman EF. The effects of ticrynafen in the rat. Res Commun Chem Pathol Pharmacol 25:63-63, 1979.
• Homandberg GA, Minor ST, Peanasky RJ. Modification of carboxypeptiadase A active site residue Glu-270 prevents interactions with a protein procasc inhibitor from Ascaris. Biochim Biophys Acta 61:384-394, 1980.
• Peanasky RJ, Bentz Y, Homandberg GA, Minor ST, Babin DR. The isoinhibitors of chymotrypsin/clastase from Ascaris lumbricoides: Isolation by affinity chromatography and association with the enzymes. Arch Biochem Biophys 232:127-134, 1984.
• Luck JC, Minor ST, Mann DE, Nielsen AP, Griffin JC, Wyndham CRC. Effects of bradycardia on dispersion of ventricular refractoriness in man. Am J Cardiol 55:1009-1014, 1985.
• TIMI Study Group: Thrombolysis in Myocardial Infarction (TIMI) Trials: Phase I findings. N Engl J Med 312:932-936, 1985.
• Hillis LD, Borer J, Braunwald E, Chesebro JH, Cohen LS, Dalen J, Dodge HT, Francis CK, Knatterud G, Ludbrook P, Markis JE, Mueller H, Desvigne-Nickens P, Passamani ER, Powers ER, Rao AK, Roberts R, Roberts WC, Ross A, Ryan TJ, Sobel BE, Williams DO, Zaret BL and Co-investigators: High-dose intravenous streptokinase for acute myocardial infarction: Preliminary results of a multicenter trial. J Am Cardiol 6:957-962, 1985.
• Williams DO, Borer J, Braunwald E, Chesebro JH, Cohen LS, Dalen J, Dodge II T, Francis CK, Knatterud G, Ludbrook P, Markis JE, Mueller H, Desvigne-Nickens P, Passamani ER, Powers ER, Rao AK, Roberts R. Ross A, Ryan TJ, Sobel BE, Winniford M, Zaret B and Co-investigators: Intravenous recombinant tissue type plasminogen activator in acute myocardial infarction: A report from the NHLBI Thrombolysis in Myocardial Infarction (TIMI) Phase I Trial. Circulation 73:338-346, 1986.
• Sheehan FH and TIMI Principal Investigators: The effect of intravenous thrombolytic therapy on left ventricular function: A report on tissue plasminogen activator and streptokinase from the Thrombolysis in Myocardial Infarction (TIMI) Phase I Trial. Circulation 75:817-829, 1987.
• Chesebro JH and TIMI Principal Investigators: Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: A comparision between intravenous tissue plasminogen activator and intravenous streptokinase. Circulation 76:142-154, 1987.
• TIMI Operations Committee, Braunwald E, Knatterud G, Passamani E, Robertson T: Announcement of protocol change in Thrombolysis in Myocardial Infarction (TIMI) Trial (letter). J Am Coll Cardiol 9:467, 1987.
• Mueller HS and TIMI Investigators: Thrombolysis in Myocardial Infarction (TIMI): Comparative studies of coronary reperfusion and systemic fibrinogenolysis with two forms of recombinant tissue-type plasminogen activator. J Am Coll Cardiol 10:479-490, 1987.
• TIMI Operations Committee, Braunwald E, Knatterud GL, Passamani E, Robertson LT: Update from the Thrombolysis in Myocardial Infarction (TIMI) Trial (letter). J Am Coll Cardiol 10:970, 1987.
• Williams D and TIMI Investigators: Coronary angioplasty following recombinant tissue-type plasminogen activator in acute myocardial infarction: A report from the Thrombolysis in Myocardial Infarction Trial. J Am Coll Cardiol 10:45B-50B, 1987.
• Passamani E and TIMI Investigators: The Thrombolysis in Myocardial Infarction (TIMI) Phase II Pilot: Tissue plasminogen activator (rt-PA) followed by percutaneous transluminal coronary angioplasty (PTCA). J Am Coll Cardiol 10:51B-64B, 1987.
• Rao AK and TIMI Investigators: The Thrombolysis in Myocardial Infarction (TIMI) Trial, Phase I: Hemorrhagic manifestations and changes in plasma fibrinogen and fibrinolytic system. J Am Coll Cardiol 11:1, 1988.
• Cheirif J, Zoghbi WA, Raizner AE, Minor ST, Winters WL Jr, Klein MS, DeBauche TL, Lewis JM, Roberts R, Quinones MA: Assessment of myocardial perfusion in humans by contrast echocardiography. Evaluation of regional coronary reserve by peak contrast intensity. J Am Coll Cardiol 11:737-743, 1988.
• Goldberg RK, Kleiman NS, Minor ST, Abukhalil J, Raizner AE: Comparision of quantitative coronary angiography to visual estimates of lesion severity pre and post PTCA. Am Heart J 119:178-184, 1990.
• Rodgers GP, Minor ST, Robinson K, Cromeens D, Woolbert SC, Stephens LC, Guyton JR, Wright K, Roubin GS, Raizner AE. Adjuvant therapy for intracoronary stents: Investigations in atherosclerotic swine. Circulation 82:560-569, 1990.

Medical Education & Training

Medical School: Baylor College of Medicine, Houston, TX
Residency: Baylor College of Medicine, Houston, TX
Fellowship: Baylor College of Medicine, Houston, TX
Specialty Board Certifications: Internal Medicine, Cardiovascular Disease

Gender

Male

Languages

English

Steven T Minor, MD

Specialty

Cardiovascular Diseases

Steven T Minor, MD

Billing

(512) 206-4300

Office Locations